Selected article for: "congestive heart failure and MMVD mitral valve disease"

Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
  • Document date: 2018_12_19
  • ID: r79h9yzz_216
    Snippet: Off‐label use of pimobendan may be considered for management of acute pulmonary edema or refractory congestive heart failure (CHF). However, the risk of continuous pimobendan overdose has not yet been well investigated in dogs with stable CHF. This observational study is to evaluate the potential effect of overdosing of pimobendan on cardiotoxicity with home‐based chronic therapy in myxomatous mitral valve disease (MMVD)......
    Document: Off‐label use of pimobendan may be considered for management of acute pulmonary edema or refractory congestive heart failure (CHF). However, the risk of continuous pimobendan overdose has not yet been well investigated in dogs with stable CHF. This observational study is to evaluate the potential effect of overdosing of pimobendan on cardiotoxicity with home‐based chronic therapy in myxomatous mitral valve disease (MMVD).

    Search related documents:
    Co phrase search for related documents